For TCGA-BRCA dataset, mRNA expression data had the main contribution toward the prediction of Basal-like, HER2-enriched, and Luminal A breast cancer subtypes, which is expected as PAM50 subtypes were defined based on mRNA expression data. This evidence concerns the gene ERBB2 and breast cancer.